Inventor · disambiguated record
Kevin Ronald Condroski
Also filed as: CONDROSKI KEVIN R · CONDROSKI KEVIN RONALD
44 granted patents·15 pending applications·1,058 citations·filing 1999–2025
98Inventor score
Top patents by PatentIndex Score
59 records- 0198US9493476B2Macrocyclic compounds as trk kinase inhibitorsARRAY BIOPHARMA INC·Filed 2014·Granted Nov 15, 2016·46 cites·14 claims
- 0298US7491794B2Macrocyclic compounds as inhibitors of viral replicationINTERMUNE INC·Filed 2005·Granted Feb 17, 2009·147 cites·1 claims
- 0397US9902741B2Macrocyclic compounds as TRK kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Granted Feb 27, 2018·22 cites·15 claims
- 0497US9840519B2Macrocyclic compounds as TRK kinase inhibitorsARRAY BIOPHARMA INC·Filed 2016·Granted Dec 12, 2017·21 cites·5 claims
- 0597US9750744B2Macrocyclic compounds as Trk kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Granted Sep 5, 2017·21 cites·29 claims
- 0697US9718822B2Macrocyclic compounds as Trk kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Granted Aug 1, 2017·22 cites·15 claims
- 0797US8791123B2Substituted pyrazolo[1,5-a]pyrimidine compounds as Trk kinase inhibitorsALLEN SHELLEY·Filed 2010·Granted Jul 29, 2014·94 cites·61 claims
- 0897US6579882B2Cell adhesion-inhibiting antiinflammatory compoundsABBOTT LAB·Filed 2001·Granted Jun 17, 2003·189 cites·8 claims
- 0997US6232320B1Cell adhesion-inhibiting antiinflammatory compoundsABBOTT LAB·Filed 1999·Granted May 15, 2001·234 cites·25 claims
- 1096US9796724B2Substituted pyrazolo[1,5-a]pyrimidine compounds as Trk kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Granted Oct 24, 2017·16 cites·30 claims
- 1196US9782415B2Substituted pyrazolo[1,5-a]pyrimidine compounds as Trk kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Granted Oct 10, 2017·19 cites·30 claims
- 1295US9682979B2Substituted pyrazolo [1,5-A] pyrimidine compounds as TRK kinase inhibitorsARRAY BIOPHARMA INC·Filed 2014·Granted Jun 20, 2017·27 cites·43 claims
- 1395US8933084B2Macrocyclic compounds as Trk kinase inhibitorsANDREWS STEVEN WADE·Filed 2011·Granted Jan 13, 2015·113 cites·52 claims
- 1493US11505548B2Heterocyclic compounds and their use for treatment of helminthic infections and diseasesCELGENE CORP·Filed 2020·Granted Nov 22, 2022·4 cites·23 claims
- 1593US10647730B2Macrocyclic compounds as TRK kinase inhibitorsARRAY BIOPHARMA INC·Filed 2018·Granted May 12, 2020·4 cites·15 claims
- 1693US7897607B2Cyclic compoundsTAKEDA PHARMACEUTICAL·Filed 2005·Granted Mar 1, 2011·37 cites·10 claims
- 1789US12209086B2FGFR3 inhibitor compoundsLILLY CO ELI·Filed 2023·Granted Jan 28, 2025·1 cites·44 claims
- 1888US10251889B2Substituted pyrazolo[1,5-a]pyrimidine compounds as Trk kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Granted Apr 9, 2019·4 cites·18 claims
- 1987US11878976B2FGFR3 inhibitor compoundsLILLY CO ELI·Filed 2022·Granted Jan 23, 2024·1 cites·37 claims
- 2087US9878997B2Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as TrkA kinase inhibitorsARRAY BIOPHARMA INC·Filed 2016·Granted Jan 30, 2018·4 cites·10 claims
- 2187US9562055B2Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as TrkA kinase inhibitorsALLEN SHELLEY·Filed 2012·Granted Feb 7, 2017·8 cites·61 claims
- 2287US8022222B2Glucokinase activatorsARRAY BIOPHARMA INC·Filed 2007·Granted Sep 20, 2011·7 cites·16 claims
- 2384US11697647B2RET kinase inhibitorsLILLY CO ELI·Filed 2021·Granted Jul 11, 2023·1 cites·25 claims
- 2483US8022223B22-aminopyridine analogs as glucokinase activatorsARRAY BIOPHARMA INC·Filed 2007·Granted Sep 20, 2011·5 cites·20 claims
- 2582US10323022B2Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as TrkA kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Granted Jun 18, 2019·2 cites·26 claims
- 2681US8212045B2Pyridin-2-yl-amino-1, 2, 4-thiadiazole derivatives as glucokinase activators for the treatment of diabetes mellitusAICHER THOMAS DANIEL·Filed 2008·Granted Jul 3, 2012·4 cites·9 claims
- 2778US2025122196A1Fgfr3 inhibitor compoundsLILLY CO ELI·Filed 2024·Application pending·0 cites
- 2875US12338235B2Heterocyclic compounds and their use for treatment of helminthic infections and diseasesCELGENE CORP·Filed 2022·Granted Jun 24, 2025·0 cites·34 claims
- 2975US8362037B22-aminopyridine analogs as glucokinase activatorsARRAY BIOPHARMA INC·Filed 2008·Granted Jan 29, 2013·2 cites·23 claims
- 3075US7932277B2Peptide inhibitors of hepatitis C virus replicationINTERMUNE INC·Filed 2008·Granted Apr 26, 2011·2 cites·79 claims
- 3175US2025276967A1Heterocyclic compounds and their use for treatment of helminthic infections and diseasesCELGENE CORP·Filed 2025·Application pending·0 cites
- 3273US11964968B2Compounds useful for inhibiting RET kinaseLILLY CO ELI·Filed 2023·Granted Apr 23, 2024·0 cites·23 claims
- 3373US2020291026A1Macrocyclic compounds as trk kinase inhibitorsARRAY BIOPHARMA INC·Filed 2020·Application pending·0 cites
- 3470US10758542B2Substituted pyrazolo[l,5-a]pyrimidine compounds as Trk kinase inhibitorsARRAY BIOPHARMA INC·Filed 2019·Granted Sep 1, 2020·0 cites·11 claims
- 3569US8853409B2Pyridin-2yl-amino-1, 2, 4-thiadiazole derivatives as glucokinase activators for the treatment of diabetes mellitusAICHER THOMAS DANIEL·Filed 2012·Granted Oct 7, 2014·1 cites·32 claims
- 3668US11970485B2RET kinase inhibitorsLILLY CO ELI·Filed 2022·Granted Apr 30, 2024·0 cites·24 claims
- 3768US2009111982A1Macrocyclic compounds as inhibitors of viral replicationBLATT LAWRENCE M·Filed 2008·Application pending·0 cites
- 3867US2009286843A1Macrocyclic compounds as inhibitors of viral replicationBLATT LAWRENCE M·Filed 2008·Application pending·0 cites
- 3965US11613533B2Compounds useful for inhibiting RET kinaseLILLY CO ELI·Filed 2021·Granted Mar 28, 2023·0 cites·25 claims
- 4065US2009105471A1Macrocyclic compounds as inhibitors of viral replicationBLATT LAWRENCE M·Filed 2008·Application pending·0 cites
- 4165US2009111969A1Macrocyclic compounds as inhibitors of viral replicationBLATT LAWRENCE M·Filed 2008·Application pending·0 cites
- 4263US2019359597A1Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as trka kinase inhibitorsARRAY BIOPHARMA INC·Filed 2019·Application pending·0 cites
- 4360US9079890B2Intermediates for the preparation of pyridin-2-yl-amino-1,2,4-thiadiazole derivativesARRAY BIOPHARMA INC·Filed 2014·Granted Jul 14, 2015·0 cites·12 claims
- 4455US8883828B22-aminopyridine analogs as glucokinase activatorsARRAY BIOPHARMA INC·Filed 2012·Granted Nov 11, 2014·0 cites·11 claims
- 4555US8431713B22-aminopyridine derivatives as glucokinase activatorsAICHER THOMAS DANIEL·Filed 2008·Granted Apr 30, 2013·0 cites·2 claims
- 4655US2024025891A1Heterocyclic compounds and their use for treatment of helminthic infections and diseasesCELGENE CORP·Filed 2021·Application pending·0 cites
- 4752US8354540B22-aminopyridine analogs as glucokinase activatorsARRAY BIOPHARMA INC·Filed 2011·Granted Jan 15, 2013·0 cites·18 claims
- 4849US2003220365A1Cell adhesion-inhibiting antiinflammatory compoundsFiled 2003·Application pending·0 cites
- 4949US2009099186A1Inhibitors of viral replicationBEIGELMAN LEONID·Filed 2006·Application pending·0 cites
- 5047US2009155209A1Novel macrocyclic inhibitors of hepatitis c virus replicationBLATT LAWRENCE M·Filed 2008·Application pending·0 cites
Showing the top 50 of 59 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Kevin Ronald Condroski files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →